Evidence map›Paper›PMID 40171892›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

Catalyst-Free Direct Hydrocarbonation of Terminal Alkynes Toward E-Alkene Substituted Stabilized Sulfoxonium Ylides.

Haiting Wu, Yougen Xu, An Lin, Jingyuan Liu, Huanjun Chen, Shimin Xie, Lebin Su

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Haiting WuSchool of Pharmaceutical Sciences, Guangzhou Laboratory, Guangzhou Medical University, Guangzhou, 511436, China.
Yougen XuBioland Laboratory, Guangzhou, 510005, China.
An LinBioland Laboratory, Guangzhou, 510005, China.
Jingyuan LiuBioland Laboratory, Guangzhou, 510005, China.
Huanjun ChenBioland Laboratory, Guangzhou, 510005, China.
Shimin XieState Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, Hunan University, Changsha, 410082, China.
Lebin SuSchool of Pharmaceutical Sciences, Guangzhou Laboratory, Guangzhou Medical University, Guangzhou, 511436, China.ORCID https://orcid.org/0000-0003-1039-0308

Funding

Guangdong Basic and Applied Basic Research Foundation 2019A1515111111Guangdong Basic and Applied Basic Research Foundation 2024A1515012583National Natural Science Foundation of China 22002169National Natural Science Foundation of China 22372044
6 · The paper itself

Abstract

Amide and alkene moieties are frequently found in natural products and are privileged structures in pharmaceuticals and agrochemicals. Moreover, vinyl sulfoxonium ylide can be converted into a broad range of high-value compounds, thus they have been widely employed in organic synthesis. However, the synthesis of alkene-substituted amide-sulfoxonium ylides via intermolecular hydrocarbonation of alkynes remains underexplored. This study describes the development of a high-throughput approach to provide diverse functionalized E-alkene substituted (hetero)amide-sulfoxonium ylides. The reaction occurs under mild metal-free conditions, employing amide-sulfoxonium ylides as highly effective nucleophiles, which participate in Michael addition reactions with various substituted alkynes, such as esters, thioesters, ketones, amides, and sulfones. This low-cost, operationally simple approach has a broad substrate scope, high functional group compatibility, and excellent regio- and stereoselectivity, making it suitable for the transformation of structurally complex molecules. Furthermore, the obtained stabilized sulfoxonium ylide products are directly useful for the synthesis of diverse valuable 1,5-dicarbonyl and thiabenzene 1-oxide compounds.

Indexed as

1,5‐dicarbonyl compoundsamide‐sulfoxonium ylidehigh‐throughput experimentationhydrocarbonationterminal alkynes

Identifiers

PMID40171892
PMCPMC12165105

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.